Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To compare the efficacy of golimumab with pamidronate in the treatment of axial spondyloarthropathy
Epistemonikos ID: 55f650d8e9ce28cf5a2304e505f923b31b19f2e4
First added on: May 11, 2024